O6.8. GLUTAMATERGIC DYSFUCTION AND TREATMENT RESPONSE IN MINIMALLY TREATED AND CHRONIC SCHIZOPHRENIA PATIENTS

BACKGROUND: Glutamatergic dysfunction as a result of NMDA receptor hypofunction has been implicated in antipsychotic treatment-resistant schizophrenia, however its nature in very early stages and chronic stages of the disease is still unknown. Data on glutamate and treatment response are currently l...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Schizophr Bull
Главные авторы: Mouchlianitis, Elias, Vanes, Lucy, Barry, Erica, Patel, Krisna, Wong, Katie, Porfy, Lilla, Shergill, Sukhi
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2018
Предметы:
Abstracts
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5887993/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sby015.229
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы